ANTI-CARDIOLIPIN ANTIBODY (IGM-ACA) TEST— 510(k) K933788

Substantially Equivalent

Immco Diagnostics, Inc.

FDA 510(k) clearance K933788 for ANTI-CARDIOLIPIN ANTIBODY (IGM-ACA) TEST, Substantially Equivalent on 1995-03-07. Applicant: Immco Diagnostics, Inc..

Clearance details

Applicant
Immco Diagnostics, Inc.
Product code
Code MID
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Buffalo, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.